PulseAugur / Brief
EN
LIVE 09:25:11

Brief

last 24h
[4/4] 222 sources

Multi-source AI news clustered, deduplicated, and scored 0–100 across authority, cluster strength, headline signal, and time decay.

  1. Shenzhen Stock Exchange: This week, regulatory measures were taken against 229 cases of abnormal securities trading activities.

    The Shenzhen Stock Exchange took regulatory action against 229 instances of abnormal securities trading between May 18th and May 22nd, 2026. These actions targeted manipulative trading practices such as price manipulation and false declarations. Additionally, the exchange reviewed five significant corporate events involving listed companies. AI

  2. Shanghai and Shenzhen ETF Total Scale Returns Above 5.1 Trillion Yuan at the End of April

    The total market value of Exchange Traded Funds (ETFs) listed on the Shanghai and Shenzhen stock exchanges has surpassed 5.1 trillion yuan as of the end of April, showing an increase from the previous month. Industry experts observe that the Chinese ETF market is shifting from a focus on broad-based indices to a more diversified approach, incorporating sector-specific, strategy-based, and cross-border themes. This evolution is supported by regulatory encouragement for long-term investment and improvements in ETF registration and issuance mechanisms, signaling a new phase of high-quality development for ETF businesses. AI

    IMPACT This development indicates increased investor confidence and diversification in China's financial markets, potentially impacting capital flows into technology and innovation sectors.

  3. SZSE: Hong Kong Stock Connect eligible securities list adjusted, Huachuang Technology included

    The Shenzhen Stock Exchange has announced adjustments to the eligible securities list for the Hong Kong Stock Connect program, effective May 21, 2026, which includes the addition of Huaqin Technology. In separate financial news, the Shanghai and Shenzhen stock exchanges reported an increase in their combined margin trading balances, totaling 2.87 trillion yuan. Additionally, the封测 (sealing and testing) sector leader, Changdian Technology, has seen its market value surpass 100 billion yuan following a significant price surge. AI

  4. Xingqi Pharmaceutical: Terminating Private Placement and Withdrawing Application Documents

    Xingqi Pharmaceutical has decided to terminate its private placement of A-shares, citing market conditions and its development plans. The company has withdrawn its application documents with the Shenzhen Stock Exchange, stating this decision will not significantly impact its operations. Separately, shareholders of Zhongxin Saike plan to reduce their holdings by up to 1.84% of the company's total share capital. AI